Juliana Alves Rodrigues

3PUBLICATIONS
11CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|May 29, 2024
The inhibitor of the redox activity of APE1/REF-1, APX2009, reduces the malignant phenotype of breast cancer cells.

P B Siqueira, M M S Rodrigues, Ĺ S S de Amorim

|Jan 02, 2024
The APE1/REF-1 and the hallmarks of cancer.

Priscyanne Barreto Siqueira, Mariana Moreno de Sousa Rodrigues, Ísis Salviano Soares de Amorim

|Feb 06, 2021
5-Aza-2'-deoxycytidine induces a greater inflammatory change, at the molecular levels, in normoxic than hypoxic tumor microenvironment.

Ísis Salviano Soares de Amorim, Juliana Alves Rodrigues, Pedro Nicolau

Pageof 1